Evidence map›Paper›PMID 41686256›Full record

ArticleHuman genetics2026

RPGRorf15 nanopore long-read sequencing improves retinitis pigmentosa molecular diagnosis for men and women.

Manon Fabard, Aurore Devos, Anaïs F Poncet, Jean-Pascal Meneboo, Martin Figeac, Céline Villenet, Isabelle Drumare, Sabine Defoort-Dhellemmes, Isabelle Meunier, Xavier Zanlonghi and 5 more

Abstract read
In one paragraph

Article in Human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Manon FabardUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Aurore DevosUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Anaïs F PoncetUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Jean-Pascal MenebooUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, 59000, Lille, France.
Martin FigeacUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, 59000, Lille, France.
Céline VillenetUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, 59000, Lille, France.
Isabelle DrumareService d'Exploration de la Vision et de Neuro-Ophtalmologie, CHU Lille, Hôpital Salengro, 59037, Lille, France.
Sabine Defoort-DhellemmesService d'Exploration de la Vision et de Neuro-Ophtalmologie, CHU Lille, Hôpital Salengro, 59037, Lille, France.
Isabelle MeunierInstitute for Neurosciences of Montpellier (INM), University of Montpellier, INSERM, Montpellier, France.
Xavier ZanlonghiService d'Ophtalmologie, Centre de compétence maladie rare, Centre Hospitalier Universitaire de Rennes, Rennes, Bretagne, France.
Olivier GrunewaldUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Vincent HuinUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Claire LecigneUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Vasily SmirnovUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France.
Claire-Marie DhaenensUniversity of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, 59000, Lille, France. claire-marie.dhaenens@chu-lille.fr.ORCID http://orcid.org/0000-0003-4719-4124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RPGR (Retinitis Pigmentosa GTPase Regulator) is the main gene involved in X-linked retinitis pigmentosa (RP) and up to 28% of sporadic RP. Pathogenic variants are mostly located in its retina-specific transcript, RPGRorf15, especially in the terminal exon named open reading frame 15 (ORF15), which is a highly repeated region. Because of this complex sequence, first- and second-generation short-read sequencing are difficult, both for male patients and for affected and relative females, resulting in numerous unresolved cases. Long-read sequencing appears to be the most appropriate to counter this problem. Using Oxford Nanopore Technology sequencing, we analysed 194 patients with retinal dystrophy (RD) (142 men and 52 women) suspected to be either X-linked (n = 42) or autosomal (n = 152), and for whom first-line sequencing of 230 retinal dystrophy genes, including RP2 and RPGRex1-19, was negative. Pathogenic ORF15 variants were found in 27 patients (13.9%), 21 men and 6 women. Of the 42 XLRD patients, 15 were carriers (35.7%), nine men and six women, most of them had rod-cone dystrophy. Of the 152 patients with isolated RD, only 12 carried ORF15 variants (7.9%),all male patients, most of them had cone-rod dystrophy (41.7%). We demonstrate the efficacy of this technology to diagnose male cases with a family history of X-linked RD, as well as sporadic cases clinically not suggestive of ORF15. We also show how easy it is to analyse female carriers or affected women. We expect that more heterozygous women with severe disease and no family history will be identified by this technique in the future.

Indexed as

Eye ProteinsNanopore SequencingRetinitis PigmentosaFemaleGenetic Diseases, X-LinkedHumansMaleMutationEye ProteinsRPGR protein, human

Identifiers

PMID41686256
PMCPMC12904915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.